Effects of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeted combined chemotherapy on immune function, tumor markers and oxidative stress in patients with stage IV lung adenocarcinoma

OBJECTIVE: To investigate the effects of EGFR-TKI combined chemotherapy on immune function, tumor markers and oxidative stress in patients with stage-IV lung adenocarcinoma. METHODS: This retrospective observational study included 116 patients with stage-IV lung adenocarcinoma, treated in The First...

Descripción completa

Detalles Bibliográficos
Autores principales: Kun, Yanxiao, Wu, Jian, Chen, Shaomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214797/
https://www.ncbi.nlm.nih.gov/pubmed/37250563
http://dx.doi.org/10.12669/pjms.39.3.7397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214797/
https://www.ncbi.nlm.nih.gov/pubmed/37250563
http://dx.doi.org/10.12669/pjms.39.3.7397

Ejemplares similares